|
Navigation
Recherche
|
IBM Watson Health cuts back Drug Discovery 'artificial intelligence' after lackluster sales
vendredi 19 avril 2019, 01:07 , par TheRegister
And seemingly uses machine learning to explain why it's kinda not but kinda is
IBM Watson Health is tapering off its Drug Discovery program, which uses 'AI' software to help companies develop new pharmaceuticals, blaming poor sales.…
go.theregister.com/feed/www.theregister.co.uk/2019/04/18/ibm_watson_health/
|
56 sources (32 en français)
Date Actuelle
sam. 20 avril - 05:49 CEST
|
Lire la suite sur TheRegister